An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma
Clinical trial NCT01898585 · COMPLETED
Trial details
- NCT number
- NCT01898585
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-17
- Primary completion
- 2019-05-22
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.